Snøve, an investment director for Aker BioMarine ASA, replaces former Epax CEO Terje Bakken.
The board of directors at omega-3 concentrates supplier Epax AS (Oslo, Norway) named Ola Snøve its new CEO, the company announced Thursday.
Snøve, an investment director for Aker BioMarine ASA (Oslo), replaces Terje Bakken as Epax’s CEO, effective immediately. Aker is a joint venture between Epax and Lindsay Goldberg LLC (New York City).
With Snøve as its new CEO, Epax will continue its work in omega-3 concentrates and its development of a triglyceride-lowering drug.
Snøve’s background includes postdoctoral research at the Norwegian University of Science and Technology Department of Cancer Research and Molecular Biology and City of Hope’s Beckman Research Institute in California. He holds an MSc in mechanical engineering and a PhD in computer science from the Norwegian University of Science and Technology, and an MBA from INSEAD in France.
Continuing innovation in algae-DHA: Natural Products Expo West 2024 Report
March 26th 2024At this year’s Natural Products Expo West, two brands have launched their own versions of algae DHA ingredients; FrieslandCampina and Aker BioMarine. Each brand showcased a different approach to the ingredient.